First Look Analyst Calls Briefing for Monday, October 31, 2022
Here's a first look analysts' research calls for Monday morning.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110
> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160
Downgrades:
> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman
> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60
> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James
> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James
Others:
> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13
> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.